This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Profound Medical (PRN) Receives a Buy from Lake Street

Tipranks - Tipranks - Tue May 19, 10:20AM CDT

Lake Street analyst Ben Haynor reiterated a Buy rating on Profound Medical today and set a price target of $12.00.

Claim 55% Off TipRanks

Haynor covers the Healthcare sector, focusing on stocks such as Senseonics Holdings, Profound Medical, and Treace Medical Concepts. According to TipRanks, Haynor has an average return of -8.0% and a 33.06% success rate on recommended stocks.

Profound Medical has an analyst consensus of Moderate Buy, with a price target consensus of $10.99.

See today’s best-performing stocks on TipRanks >>

Based on Profound Medical’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of C$5.25 million and a GAAP net loss of C$6.94 million. In comparison, last year the company earned a revenue of C$2.62 million and had a GAAP net loss of C$10.72 million

Based on the recent corporate insider activity of 28 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PRN in relation to earlier this year.

Read More on TSE:PRN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).